MedPath

The Effect of Suspension Laryngoscopy Application on Optic Nerve Sheath Diameter, an Indirect Indicator of Increased Intracranial Pressure

Not Applicable
Completed
Conditions
suspension laryngoscopy
Raised intracranial pressure
Surgery - Other surgery
Anaesthesiology - Other anaesthesiology
Neurological - Other neurological disorders
Registration Number
ACTRN12622000157774
Lead Sponsor
ecmettin Erbakan University Meram Faculty of Medicine
Brief Summary

One of the non-invasive procedures used in intracranial pressure monitoring is ultrasonography measurement of optic nerve sheath diameter (ONSD). Laryngoscopy is a procedure that induces hemodynamic alterations as well as increased intracranial pressure. Many procedures have examined intracranial pressure change with ONSD measurement. However, no research has been conducted to investigate the influence of suspension laryngoscopy on ONSD measures. The effect of suspension laryngoscopy on ONSD readings and intracranial pressure was studied in this study.The study included 50 patients, ASA I-III, aged 18-90 years, who were scheduled for suspension laryngoscopy. ONSD measurements were taken after anesthesia induction (T0), intubation (T1), when the neck was in hyperextension at the start of the suspension laryngoscopy (T2), at the end of the suspension laryngoscopy (T3), and 5 minutes after the suspension was terminated and the neck was brought to the straight position (T4). The highest measurements were detected in T2 and T3. laryngoscopy causes a significant increase in ONSD measurements. Suspension time, on the other hand, does not result in a progressive increase. Ending the suspension by straightening the neck at the end of the surgery permits ONSD measurements to approach the baseline values.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

ASA I-III, 18-90 years old patients who will undergo suspension laryngoscopy will be included in the study.

Exclusion Criteria

Patients with intracranial pathology, a history of cerebrovascular disease, a history of ocular pathology or disease, and pregnant women will be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath